Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Adia Nutrition Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Adia Nutrition Inc (ADIA) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
145.54 %
Q1 2026
Net Margin
-92.17 %
Q1 2026

Key Findings: Adia Nutrition Inc vs Its Competitors

  • Peer revenue share: Adia Nutrition Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

ADIA Sales vs. its Competitors, Q1 2026

Adia Nutrition Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/ADIA/competitors
https://api.csimarket.com/api/v1/companies/ADIA/relationships
https://api.csimarket.com/api/v1/companies/ADIA/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Legal Cannabis industry grew revenue 34.7% year over year, combined, vs 145.5% for Adia Nutrition Inc. Adia Nutrition Inc's share of combined industry revenue moved from 0.00% to 0.01%, a gain of 0.00 percentage points.

Market Share of the Peer Group, Q1 2026

100%market share
  • Adia Nutrition Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Adia Nutrition Inc and its 0 tracked competitors.

See Adia Nutrition Inc's full market share breakdown »

ADIA Stock Performance relative to its Competitors

ADIA Competitors (weighted) Percent change over the selected range

Adia Nutrition Inc's Comment on Competition and Industry Peers

The regenerative tissue products market is moderately fragmented, with approximately 30 to 50 competitors offering amniotic-based or umbilical cord-based products. Many competitors face funding challenges, resulting in financial attrition and some consolidation within the industry. The company ADIA is identified as focusing on applications within the regenerative medicine market. Currently, the pharmaceutical industry does not participate in the regenerative tissue segment, as it primarily focuses on providing cures for medical conditions; however, it is anticipated that pharmaceutical companies may enter the regenerative care market in the future through acquisitions as consolidation occurs.